Fulvio Braido
A5029463785- Asthma and respiratory diseases
- Respiratory and Cough-Related Research
- Allergic Rhinitis and Sensitization
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Inhalation and Respiratory Drug Delivery
- Pediatric health and respiratory diseases
- Respiratory Support and Mechanisms
- Olfactory and Sensory Function Studies
- Dermatology and Skin Diseases
- Urticaria and Related Conditions
- Delphi Technique in Research
- Infant Health and Development
- Pharmaceutical studies and practices
- Autoimmune Bullous Skin Diseases
- Food Allergy and Anaphylaxis Research
- Health and Medical Studies
- Health Systems, Economic Evaluations, Quality of Life
- Eosinophilic Esophagitis
- Obstructive Sleep Apnea Research
- Immune Cell Function and Interaction
- Cystic Fibrosis Research Advances
- Patient-Provider Communication in Healthcare
- Health, psychology, and well-being
- Behavioral Health and Interventions
- Respiratory viral infections research
Ospedale Policlinico San Martino
2016-2025
University of Genoa
2016-2025
Asthma Association
2024
Istituti di Ricovero e Cura a Carattere Scientifico
2014-2023
Ospedale Papa Giovanni XXIII
2019
University of Milan
2014-2019
Fractionnation of AgroResources and Environment
2018
Martin University
2017
Humanitas University
2016
University of Naples Federico II
2015
Background: Health‐related quality of Life in patients with chronic urticaria is evaluated by mean generic instruments or questionnaire designed for skin diseases. No disease‐specific tool now available the assessment impact from patients’ viewpoint. Objective: The aim our study to develop and validate a new specifically life (Chronic Urticaria Quality Questionnaire – CU‐Q 2 oL) Methods: In development phase oL an initial list items 37 was compiled given 80 urticaria; 23 most significant...
Background: Few articles are available about chronic urticaria (CU) impact on patients’ quality of life (QoL). The aim our study was to evaluate QoL in CU patients both focusing health status and subjective satisfaction. We adopted two generic tools: SF‐36 (an questionnaire) SAT‐P (a satisfaction profile). Methods: Twenty‐one untreated (five males, 16 females; aged 46.3 ± 12.4) affected by CU, were enrolled. scores compared with a group 27 respiratory allergy. Published reference values 608...
Abstract In less than half a century, allergy, originally perceived as rare disease, has become major public health threat, today affecting the lives of more 60 million people in Europe, and probably close to one billion worldwide, thereby heavily impacting budgets systems. More disturbingly, its prevalence impact are on rise, development that been associated with environmental lifestyle changes accompanying continuous process urbanization globalization. Therefore, there is an urgent need...
According to the Global Initiative of Asthma, aim asthma treatment is gain and maintain control. In INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study, we evaluated level control quality life (QoL), as well their determinants impact in a population consulting specialist settings. LIAISON prospective, multicentre, observational study with cross-sectional 12-month longitudinal phase. Adults an diagnosis since at least 6 months, receiving same 4 weeks...
Although there are many asymptomatic patients, one of the problems COVID-19 is early recognition disease. symptoms polymorphic and may include upper respiratory symptoms. However, be mistaken with common cold or allergic rhinitis. An ARIA-EAACI study group attempted to differentiate between three diseases.A modified Delphi process was used. The ARIA members who were seeing patients asked fill in a questionnaire on airway COVID-19, rhinitis.Among 192 invited respond questionnaire, 89...
MASK-air
Background: Benralizumab has been shown to restore good control of severe eosinophilic asthma (SEA). Robust data on benralizumab effectiveness over periods longer than 2 years are scarce. Methods: This retrospective multicentric study was conducted 108 Italian SEA patients treated with for up 36 months. Partial and complete clinical remission (CR) were assessed. Data analyzed descriptive statistics or using linear, logistic, negative binomial mixed-effect regression models. Results: At...
Introduction: To date we have available specific instruments assessing health‐related quality of life (HRQL) in rhinoconjunctivitis or asthma, but not evaluating rhinitis and asthma together, although they often coexist. The aim our study was to develop validate a (QoL) questionnaire for adult patients with rhinoconjunctivitis, both. Materials methods: A pool 42 items covering the main symptoms problems related respiratory allergy, generated based on literature review clinical experience....
The aim of this Global Allergy and Asthma European Network (GA(2)LEN) consensus report is to provide recommendations for patient-reported outcomes (PROs) evaluation in clinical trials allergic diseases, which constitute a global health problem terms physical, psychological economic social impact. During the last 40 years, PROs have gained large consideration use scientific community, gain better understanding patients' subjective assessment with respect elements concerning their condition....
Purpose: Despite the high and increasing prevalence of allergic diseases in athletes, allergy diagnostics is not part routine medical examination sports medicine. This study reports development validation an easy reliable questionnaire for screening athletes. Methods: AQUA© was derived from European Community Respiratory Health Survey Questionnaire. On basis open interviews with team doctors, coaches, questions were added about: type, duration, intensity training; exercise-related infectious...
To cite this article: Baiardini I, Braido F, Bindslev-Jensen C, Bousquet PJ, Brzoza Z, Canonica GW, Compalati E, Fiocchi A, Fokkens W, Gerth van Wijk R, Giménez-Arnau Godse K, Grattan Grob JJ, La Grutta S, Kalogeromitros D, Kocatürk Lombardi Mota-Pinto Ridolo Saini SS, Sanchez-Borges M, Senna GE, Terreehorst Todo Bom Toubi J, Zuberbier T, Maurer M. Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA2LEN taskforce...